| ABC | ATP-binding cassette |
| ABCB1 | ATP-binding cassette subfamily b member 1 (P-glycoprotein) |
| ABCB1/Flp-In TM-293 | Flipase recombinase-compatible human embryonic kidney 293 with transfected human ABCB1 |
| ABCC1 | ATP-binding cassette subfamily c member 1 (multidrug resistance-associated protein 1) |
| ABCC1/Flp-In TM-293 | Flipase recombinase-compatible human embryonic kidney 293 with transfected human ABCC1 |
| ABCC2 | ATP-binding cassette subfamily c member 2 (multidrug resistance-associated protein 2) |
| ABCC3 | ATP-binding cassette subfamily c member 3 (multidrug resistance-associated protein 3) |
| ABCG2 | ATP-binding cassette subfamily g member 2 (breast cancer resistance protein) |
| ABCG2/Flp-In TM-293 | Flipase recombinase-compatible human embryonic kidney 293 with transfected human ABCG2 |
| ABCT | ATP-binding cassette transporter |
| AC261066 | RARβ-2 agonist |
| ALDH1 | Aldehyde dehydrogenase 1 |
| ALDH1A1 | Aldehyde dehydrogenase 1 family member 1A |
| AML | Acute myeloid leukemia |
| APL | Acute promyelocytic leukemia |
| ARE | Antioxidant response element |
| ATO | Arsenic trioxide |
| ATP | Adenosine triphosphate |
| ATPase | Adenosine triphosphatase |
| ATRA | All-trans-retinoic acid |
| A2780/RCIS | Human ovarian cancer, cisplatin-resistant subline |
| BCRP | Breast cancer resistance protein |
| Caco-2 | Human colon cancer |
| CAR | Constitutive androstane receptor |
| CARET | Carotene and Retinol Efficacy Trial |
| CD437 | RAR-γ selective agonist |
| CD44 | Cluster of Differentiation 44 |
| CEM/ADR5000 | Human acute lymphoblastic leukemia (T-cell type), doxorubicin-resistant subline |
| Colo 320 | Human colon cancer overexpressing ABCB1 and lung resistant protein (LRP) |
| CSC | Cancer stem cell |
| CYP3A4 | Cytochrome P450 3A4 |
| CYP450 | Cytochrome P450 |
| EC19 | 3-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-ylethynyl)benzoic acid |
| EC23 | 4-(5,5,8,8-tetramethyl-5,6,7,8-tetrahydronaphthalen-2-ylethynyl)benzoic acid |
| EPG85-257 | Human gastric carcinoma |
| EPG85-257RDB | Human gastric carcinoma, doxorubicin-resistant subline |
| Egr1 | Early growth response 1 gene |
| FAB | French-American-British classification system of AML |
| FAR | Fluorescence activity ratio |
| FDA | Food and Drug Administration |
| FK228 | Histone deacetylase inhibitor (HDACI), Romidepsin (depsipeptide) |
| FOXP1 | Forkhead box protein P1 |
| 5-FU | 5-Fluorouracil |
| GST | Glutathione S-transferase |
| hCAR | Human constitutive androstane receptor |
| HeLaS3 | Human cervical carcinoma |
| HepG-2 | Human hepatocellular carcinoma |
| HepG-2/Dox | Human hepatocellular carcinoma, doxorubicin-resistant subline |
| HIF-1α | Hypoxia-inducible factor 1-alpha |
| HL-60/RS | Multidrug-resistant human acute promyelocytic leukemia cells overexpressing ABCB1, ABCC1, and ABCG2 |
| HT29 | Human colon cancer |
| H3-Lys9 | Histone H3 at lysine 9 |
| H9 | Human acute T-cell leukemia |
| H9/RAR | RARα transfected human acute T-cell leukemia |
| IC50 | Half-maximal inhibitory concentration |
| IIF | 6-OH-11-O-hydroxyphenanthrene |
| Kasumi-1 | Human acute myeloid leukemia with t(8:21) karyotype |
| Kasumi-6 | Human acute myeloid leukemia |
| KB-vin | Human cervical carcinoma, vincristine-resistant subline |
| Keap1 | Kelch-like ECH-associated protein 1 |
| KG-1 | Human acute myeloid leukemia |
| KG-1/RAR | RARα transfected human acute myeloid leukemia |
| K562 | Human cell line from the patient in blast crisis of chronic myeloid leukemia |
| K562/RAR | RARα transfected human cell line from the patient in blast crisis of chronic myeloid leukemia |
| LoVo/MDR | Human colorectal cancer, doxorubicin-resistant subline |
| LRP | Lung resistant protein |
| LS174T | Human colorectal carcinoma |
| L1210/R | Mouse lymphocytic leukemia, subline with ABCB1-overexpression induced by vincristine |
| L1210/S | Mouse lymphocytic leukemia/without detectable ABCB1 expression and efflux activity |
| L1210/T | Mouse lymphocytic leukemia, subline with ABCB1 overexpression induced by transfection |
| L1210/VCR | Mouse lymphocytic leukemia, vincristine-resistant subline |
| L5178Y (MDR1/A) | Mouse T-cell lymphoma cells transfected by human ABCB1 gene |
| MAF | Multidrug Activity Factor |
| MCF-7 | Human breast cancer |
| MCF-7/Doc | Human breast cancer, docetaxel-resistant subline |
| MCF-7/Dox | Human breast cancer, doxorubicin-resistant subline |
| MCF-7/Pac | Human breast cancer, paclitaxel-resistant subline |
| MCF-7/Vinc | Human breast cancer, vincristine-resistant subline |
| MDA-MB-231 | Human triple-negative breast cancer |
| MDA-MB-468 | Human triple-negative breast cancer |
| MDCK ABCG2 | Madine-Darby canine kidney cell line overexpressing ABCG2 |
| MDR | Multidrug resistance |
| MDR1 | Multidrug resistance protein 1 |
| mdr1 | Multidrug resistance 1 gene (the rodent equivalent of human ABCB1) |
| mdr2 | Multidrug resistance 2 gene |
| mdr3 | Multidrug resistance 3 gene |
| MM CS-like cells | Cancer stem cells derived from spheroids of human A375 melanoma cells |
| MRP1 | Multidrug resistance-associated protein 1 (ABCC1) |
| MRP2 | Multidrug resistance-associated protein 2 (ABCC2) |
| MRP3 | Multidrug resistance-associated protein 3 (ABCC3) |
| MTT | Methyltiazoltetrazolium assay |
| MVP | Major vault protein/Lung resistant protein |
| M1 | Acute myeloblastic leukemia without maturation |
| M2 | Acute myeloblastic leukemia with maturation with t(8;21) karyotype |
| M3 | Acute promyelocytic leukemia |
| M4 | Acute myelomonocytic leukemia |
| NB4 | Human acute promyelocytic leukemia |
| NB4/RAR | RARα transfected human acute promyelocytic leukemia |
| NCI-H460 | Human non-small-cell lung carcinoma |
| NCI-H460/MX20 | Human non-small-cell lung carcinoma, mitoxantrone-resistant subline |
| NF-YA | Nuclear transcription factor Y alpha |
| NF-κB | Nuclear factor kappa-B |
| NIH 3T3 MDR1 | Mouse fibroblast cell line overexpressing ABCB1 |
| Nrf2 | Nuclear factor erythroid 2-related factor 2 |
| NT2 | Human pluripotent embryonal carcinoma |
| PARPi | Poly ADP-ribose polymerase inhibitor |
| PI3K/Akt/mTOR | Phosphoinositide 3-kinase/protein kinase B/mechanistic target of rapamycin signaling pathway |
| PXR | Pregnane X receptor |
| RAR | Retinoic acid receptor |
| RFX1 | Regulatory factor X1 |
| Rh-123 | Rhodamine 123 |
| ROS | Reactive oxygen species |
| RT-PCR | Real-time quantitative polymerase chain reaction |
| RXR | Retinoid X receptor |
| SKOV-3 | Human ovarian adenocarcinoma |
| SKOV-3/Dox | Human ovarian adenocarcinoma, doxorubicin-resistant subline |
| SOX9 | SRY-box transcription factor 9 |
| SOX10 | SRY-box transcription factor 10 |
| SRC-1 | Steroid receptor coactivator-1 |
| SW620 | Human colon cancer |
| VER | Verapamil |
| WIPO | World Intellectual Property Organization |
| WNT/β-catenin | Wingless-related integration site/β-catenin |
| WT1 | Wilms’ tumor suppressor gene |
| W1PR | Human ovarian cancer, paclitaxel-resistant subline (primary cell line) |
| W1TR | Human ovarian cancer, topotecan-resistant subline (primary cell line) |